As such, a study described that microRNA‐433‐3p is underexpressed in glioma tissue and cells and activates apoptotic‐signaling pathway to enhance glioma chemosensitivity to temozolomide by targeting CREB (Sun et al., 2017). This evidence concerns the gene CREB1 and central nervous system cancer.